IP Library › Granted Patent US 10,633,709
Granted Patent B2
US 10,633,709 · App. 15/491,327 · Granted Apr 28, 2020

Method and apparatus for diagnosing a tumor using a histogram and excluding abnormal fluorescence corresponding to DNA aneuploidy

Inventors: Takahiro Shioyama (Tokyo, JP); Akane Suzuki (Tokyo, JP); Yoshitaka Amano (Tokyo, JP)
Assignee: NIHON KOHDEN CORPORATION
C12Q1/6886G01N15/1459G01N21/6428G01N21/6486G01N15/1429G01N2015/1006G01N2015/1486G01N2015/1488G01N2021/6439
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,633,709
App. No.
15/491,327
Granted
Apr 28, 2020
Kind
B2
Abstract

An apparatus and a method for diagnosing a tumor are provided. A histogram generating section generates a histogram from a result of a measurement of fluorescence intensity of a suspension produced from a target sample. The histogram indicates a relation between the fluorescence intensity and the number of cells. A determination section detects an S phase fluorescence intensity range corresponding to S phase cells based on the fluorescence intensity corresponding to a peak of the number of cells in the histogram, detects an abnormal fluorescence intensity range corresponding to tumor cells, based on a change in the number of cells in the S phase fluorescence intensity range, and performs a diagnosis of a tumor in the target sample based on an index of the number of cells in a range defined by excluding the abnormal fluorescence intensity range from the S phase fluorescence intensity range.

Claims (28)

1. A tumor diagnostic apparatus comprising:

a non-transitory computer readable medium storing a program;

and a processor configured to execute the program including the following the steps:

generating a histogram from a result of a measurement of fluorescence intensity of a suspension, the suspension having been produced from a target sample and comprising a cell containing DNA that is fluorescently stained, the histogram being indicative of a relation between the fluorescence intensity and a number of cells; and

analyzing the histogram and performing a diagnosis of a tumor in the target sample,

wherein the performing the diagnosis comprises:

detecting an S phase fluorescence intensity range corresponding to S phase cells based on the fluorescence intensity corresponding to a peak of the number of cells in the histogram,

detecting an abnormal fluorescence intensity range corresponding to tumor cells in which DNA aneuploidy has occurred, based on a change in the number of cells in the S phase fluorescence intensity range, and

performing the diagnosis of the tumor in the target sample based on an index of the number of cells in a modified range defined by excluding the abnormal fluorescence intensity range from the S phase fluorescence intensity range.

2. The tumor diagnostic apparatus according to claim 1 , wherein the diagnosis of the tumor is a determination of a type of the tumor or a determination of malignancy of the tumor.

3. The tumor diagnostic apparatus according to claim 1 , wherein analyzing the histogram compares a representative value of the number of cells in the modified range with a value of the peak in the histogram to perform the diagnosis of the tumor in the target sample.

4. The tumor diagnostic apparatus according to claim 3 , wherein the representative value is a mean value, a mode value, or a median value.

5. The tumor diagnostic apparatus according to claim 1 , wherein the determination section compares an area under a curve in the modified range with an area under a curve in an entire range of the histogram to perform the diagnosis of the tumor in the target sample.

6. The tumor diagnostic apparatus according to claim 1 , wherein the determination section compares an area under a curve in the modified range with an area under a curve in a range defined by excluding a range corresponding to debris from an entire range of the histogram to perform the diagnosis of the tumor in the target sample.

7. A tumor diagnostic method comprising:

generating a histogram from a result of a measurement of fluorescence intensity of a suspension, the suspension having been produced from a target sample and comprising a cell containing DNA that is fluorescently stained, the histogram being indicative of a relation between the fluorescence intensity and a number of cells; and

performing a diagnosis of a tumor in the target sample by analyzing the histogram,

wherein the performing the diagnosis comprises:

detecting an S phase fluorescence intensity range corresponding to S phase cells based on the fluorescence intensity corresponding to a peak of the number of cells in the histogram;

detecting an abnormal fluorescence intensity range corresponding to tumor cells in which DNA aneuploidy has occurred, based on a change in the number of cells in the S phase fluorescence intensity range; and

performing the diagnosis of the tumor in the target sample based on an index of the number of cells in a range defined by excluding the abnormal fluorescence intensity range from the S phase fluorescence intensity range.

8. A non-transitory computer readable medium storing a program which, when executing on a computer, causes the computer to execute a method comprising:

generating a histogram from a result of a measurement of fluorescence intensity of a suspension, the suspension having been produced from a target sample and comprising a cell containing DNA that is fluorescently stained, the histogram being indicative of a relation between the fluorescence intensity and a number of cells; and

performing a diagnosis of a tumor in the target sample by analyzing the histogram,

wherein the performing the diagnosis comprises:

detecting an S phase fluorescence intensity range corresponding to S phase cells based on the fluorescence intensity corresponding to a peak of the number of cells in the histogram;

detecting an abnormal fluorescence intensity range corresponding to tumor cells in which DNA aneuploidy has occurred, based on a change in the number of cells in the S phase fluorescence intensity range; and

performing the diagnosis of the tumor in the target sample based on an index of the number of cells in a range defined by excluding the abnormal fluorescence intensity range from the S phase fluorescence intensity range.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2017
From: SHIOYAMA, TAKAHIRO; SUZUKI, AKANE; AMANO, YOSHITAKA
To: NIHON KOHDEN CORPORATION
Reel/Frame 042066/0776 →
Priority Claims (1)
JP 2016-087586 · Apr 26, 2016 · national
Continuity (1)
Related Publication 20170306412A1 · Oct 26, 2017